ArticleBritish journal of cancer2020

Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer.

Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.